Related Experiment Video
Updated: Nov 6, 2025

10:20
Simultaneous Assessment of Kinship, Division Number, and Phenotype via Flow Cytometry for Hematopoietic Stem and Progenitor Cells
Published on: March 24, 2023
1.8K
Single-cell technologies and analyses in hematopoiesis and hematological malignancies
Ignacio Campillo-Marcos1, Damiana Alvarez-Errico2, Regina A Alandes3
1Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain.
Experimental Hematology
|May 12, 2021
Summary
Single-cell technologies offer unprecedented insights into blood cell variations and rare subpopulations. These advanced methods are revolutionizing the diagnosis and treatment of hematological malignancies.
Area of Science:
- Hematology
- Genomics
- Molecular Biology
Background:
- Single-cell technologies are revolutionizing the study of normal and malignant hematopoietic cells.
- These methods overcome limitations of bulk analysis by preserving cell-to-cell variation.
- Advancements enable high-throughput, sensitive multiomic profiling at the single-cell level.
Purpose of the Study:
- To review emerging single-cell techniques for assessing molecular parameters.
- To analyze how single-cell profiling enhances understanding of hematopoietic variability.
- To explore the impact of single-cell strategies on hematological malignancy characterization.
Main Methods:
- Review of emerging single-cell technologies (genetic, epigenetic, transcriptional, proteomic).
- Analysis of single-cell data for identifying rare subpopulations and tumor heterogeneity.
- Summarization of single-cell profiling applications in hematological malignancies.
Main Results:
- Single-cell methods reveal cell diversity and clonal evolution in hematological malignancies.
- These techniques identify unknown or rare subpopulations crucial for understanding disease.
- Profiling provides insights into treatment failure mechanisms and patient prognosis.
Conclusions:
- Single-cell technologies are vital for advancing hematological research and clinical practice.
- Continued development is needed to address remaining challenges in the field.
- These methods offer a powerful approach for personalized diagnosis and targeted therapies.
More Related Videos
Related Concept Videos
Hematopoiesis
7.5K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
7.5K
Multipotency of Hematopoietic Stem Cells
3.5K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.5K
Regulation of Hematopoietic Stem Cells
3.6K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.6K

